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Abstract 
Traumatic brain injury (TBI) constitutes a major cause of death and long-term 
disability. At present, we lack methods to non-invasively track tissue biochemistry 
and hence select appropriate interventions for patients. We hypothesized that 
detailed label-free vibrational chemical analysis of focal TBI could provide such 
information. We assessed the early spatial and temporal changes in tissue 
biochemistry that are associated with brain injury in mice. Numerous differences 
were observed in the spectra of the contusion core and pericontusional tissue 
between 2 and 7 days. For example, a strong signal from haem was seen in the 
contusion core at 2 days due to haemorrhage, which subsequently resolved. More 
importantly, elevated cholesterol levels were demonstrated by 7 days, which may be 
a marker of important cell repair processes. Principal component analysis revealed 
an early ‘acute’ component dominated by haemorrhage and a delayed component 
reflecting changes in protein and lipid composition. Notably we demonstrated 
changes in Raman signature with time even in the contralateral hemisphere when 
compared to sham control mice. Raman spectroscopy therefore shows promise as a 
probe that is sensitive to important pathobiological processes in TBI and could be 
applied in future both in the experimental setting, as well as in the clinic. 
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Introduction 
Traumatic brain injury (TBI) constitutes a major cause of death and long-term 
disability, including late cognitive deficits in survivors of even milder injuries. The 
societal costs of acute and chronic care, as well as from lost economic activity, for 
such patients is enormous. TBI is a complex disease whose pathogenesis continues 
for weeks after the initial injury. Progress towards improving outcome in patients has 
been limited because the complex, multifactorial pathobiology of TBI is not well 
understood; hence opportunities for therapeutic intervention are missed.  
Studies to date indicate that TBI is a disease governed by the host response 
to the injury, which varies dramatically between patients and has a complex 
spatiotemporal profile. Some commonalities include cell damage and loss of axonal 
connectivity over the first 24 hours and neuronal phospholipid membrane 
breakdown, clinically evidenced by early elevation in extracellular glycerol 
concentrations1. A variety of molecular processes, such as excitotoxicity / calcium 
influx, oxidative injury and inflammation, along with cellular changes in resident 
microglial cells and recruitment of macrophages, may continue to drive injury2–4. 
These insights have been provided by traditional experimental techniques, such as 
immunohistochemistry must be performed ex vivo and has specificity to 
predetermined epitopes only. Cerebral microdialysis can provide some chemical 
information in vivo but has poor spatial resolution and is only sensitive to small 
molecules and these must be present in the extracellular fluid. Non-invasive tools to 
track brain tissue biochemistry after injury remains an unmet need, which if met, 
could shed light on disease pathobiology and furthermore, assist clinically with 
translation of precise and timely interventions, such as neuroprotective therapies5. 
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Raman spectroscopy (RS) is a powerful label-free analytical technique that 
has been widely used to study tissue biochemistry, for example, profiling lipid, 
protein and nucleic acid composition6,7,8. All twelve major and minor human brain 
lipids can be identified using RS at 785 nm9. Previous work has revealed that RS 
can indicate brain tissue damage in response to both radiation10 and penetrating11 
injuries. In the latter study, RS was able to delineate injured and healthy brain 
regions in a mouse model of motor cortex needle injury on the basis of reduced 
signal intensity at 1660 cm-1, attributed to amide I vibration of proteins and C=C 
stretching of lipids, and at 1002 cm-1, attributed to the ring breathing mode of 
phenylalanine in proteins11. However, these data were acquired exclusively in the 
motor cortex and penetrating injury does not reflect the vast majority of TBI seen 
clinically. Furthermore, the study was conducted at a single time point immediately 
after injury, which does not provide crucial information on the evolution of the 
pathology2-4.  
We hypothesized that RS could monitor the progression and resolution of 
brain injury over space and time in a clinically relevant model of focal TBI. To test 
this hypothesis, we studied for the first time using RS the spatial and temporal 
distribution of early changes in brain biochemistry after focal severe TBI modelled by 
controlled cortical impact in mice. We found that RS provides a sensitive readout of 
the evolution of tissue injury in our model. 
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Experimental 
Animals 
C57BL/6 mice (adult male mice, Envigo, Italy) were housed in a specific 
pathogen free vivarium at a constant temperature (21±1°C) with a 12h light–dark 
cycle and ad libitum access to food and water. The IRCCS-Instituto di Ricerche 
Farmacologiche Mario Negri (IRFMN) adheres to the principles set out in the 
following laws, regulations, and policies governing the care and use of laboratory 
animals: Italian Governing Law (D.lgs 26/2014; Authorization n.19/2008-A issued 
March 6, 2008 by Ministry of Health); Mario Negri Institutional Regulations and 
Policies providing internal authorization for persons conducting animal experiments 
(Quality Management System Certificate – UNI EN ISO 9001:2008 – Reg. N° 6121); 
the NIH Guide for the Care and Use of Laboratory Animals (2011 edition) and EU 
directives and guidelines (EEC Council Directive 2010/63/UE). The Statement of 
Compliance (Assurance) with the Public Health Service (PHS) Policy on Human 
Care and Use of Laboratory Animals has been recently reviewed (9/9/2014) and will 
expire on September 30, 2019 (Animal Welfare Assurance #A5023-01). All efforts 
were made to minimize animal suffering and to reduce the number of animals used. 
Experimental Traumatic Brain Injury 
Adult male mice (11 week old) were anesthetized with isoflurane inhalation 
(induction: 3%, maintenance: 1.5%) in an N2O/O2 (70%/30%) mixture and placed in 
a stereotaxic frame. Rectal temperature was maintained at 37°C. Mice were then 
subjected to craniectomy followed by induction of controlled cortical impact brain 
injury as previously described12–15. The injury was induced using a 3 mm rigid 
impactor driven by a pneumatic piston rigidly mounted at an angle of 20° from the 
vertical plane and applied vertically to the exposed dura mater, between bregma and 
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lambda, over the left parieto-temporal cortex (antero-posteriority: –2.5 mm, laterality: 
–2.5 mm), at impactor velocity of 5 ms-1 and deformation depth of 1 mm.  The 
craniotomy was then covered with a cranioplasty and the scalp sutured. Sham 
(control)-operated mice received identical anesthesia and surgery without brain 
injury. 
Mice were sacrificed at 2 or 7 days after TBI (n=3 per time point) under deep 
anesthesia (ketamine 30 mg/medetomidine 0.3 mg). The brains were then removed, 
washed once with phosphate buffered saline (PBS) then frozen immediately into 
liquid nitrogen and stored at -80°C. Before commencing Raman analysis brains were 
thawed for 20 min at room temperature. 
Reference Chemicals 
Cholesterol (Acros Organics, CAS 57-88-5), cholesteryl nonanoate (Eastman 
Organic Chemicals, no. 9669), cholesteryl oleyl carbonate (Eastman Organic 
Chemicals, no. 10053), intralipid (Sigma, no. I141) and albumin from bovine serum 
(Sigma-Aldrich, no. A7906) were investigated. 
Raman Data Acquisition and Analysis 
Raman spectroscopy was performed with a confocal Alpha 300M+ Raman 
microscope (WITec GmbH, Ulm, Germany) equipped with a 785 nm single mode 
diode laser (XTRA II; Toptica Photonics Inc., USA), a 300 mm triple grating imaging 
spectrometer (Acton SpectraPro SP-2300; Princeton Instruments Inc., USA) with 600 
g/mm grating (BLZ = 750 nm), a thermoelectrically cooled CCD camera (DU401A-
BV; Andor, Ireland) and 20x objective (LD Plan-Neofluar; Zeiss, Germany). Although 
here we are collecting data using a confocal microscope, it should be noted that 
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previous studies have found exciting tissue at 785 nm can yield Raman signals from 
5-10 mm of depth, depending on the optical properties of the tissue16. 
Whole brain samples were placed on a 25 mm round microscope coverslip in 
a petri dish and illuminated with 35 mW at 785 nm. Single Raman spectra were 
collected with 1 s integration time and 10 accumulations. At each position 
interrogated (as indicated on the figures), at least 10 spectra were collected along a 
line scan up to 70 µm length. Total numbers of recorded Raman spectra used in the 
analysis are: contralateral (CL; n(2 days) = 330, n(7 days) = 330, n(control) = 560);  
pericontusional (PC;  n(2 days) = 330, n(7 days) = 180, n(control) = 240); contusion 
core (CC; n(2 days) = 140, n(7 days) = 240, n(control) = 360) and ipsilateral tissue 
distant from the contusion core (ID; n(2 days) = 120, n(7 days) = 120, n(control) = 
200). 
Data processing was performed using Project Plus Four 4.1 (WITec), Origin 
2016 (OriginLab) and MATLAB with PLS-Toolbox (Mathworks). All Raman spectra 
were cosmic ray and baseline corrected then normalized to the area-under-curve. 
Statistical significance was analysed using two-way ANOVA, followed by Tukey’s 
multiple comparison test. p < 0.05 was considered statistically significant. 
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Results  
Raman spectroscopy (RS) was performed at a range of spatial locations on 
the excised brains at 2 (Figure 1A) and 7 (Figure 1B) days after TBI, or in sham 
control brains (Figure 1C). The spatial locations are identified as: contralateral (CL); 
ipsilateral tissue, distant from the contusion core (ID); pericontusional (PC); and 
contusion core (CC). The injury was delivered to the left parietotemporal cortex, so 
the right hemisphere is contralateral. Significant discoloration in the injured site can 
be observed in the sample at 2 days of TBI as a result of mechanical damage to the 
tissue and associated bleeding (Figure 1A). The spatial and temporal distribution of 
the RS data (Figure 1D-F) shows dominant spectral contributions from lipids and 
proteins as expected from tissue. Example spectra from 2 days after TBI are 
annotated in detail in Figure 2; no additional peaks were identified at 7 days, so only 
data from 2 days are annotated for clarity. Comparing qualitatively the contusion 
core with the contralateral hemisphere (Figure 2A,B) at 2 days after TBI, we can see 
additional strong bands at ~754, 1224, 1547, 1562, 1620 cm-1 from haemoglobin and 
decreased intensity of the bands at around 718, 1264, 1440 and 1660 cm-1 from 
lipids. Based on the similarity in the wavenumber regions of interest between spectra 
recorded on the coordinates of contusion core in sham (control) sample to 
contralateral at 2 and 7 days after TBI (Figure 2C,D), for all further analysis we 
compared contusion, pericontusional and ipsilateral distant data to the contralateral 
side of the brain. 
 To examine the changes recorded by RS in more detail, we computed the 
differences between the average spectra across all mice at each spatial location and 
time point (Figure 3). No significant difference was observed between the 
contralateral hemisphere (CL) and ipsilateral distant (ID) measurements made at 
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‘uninjured’ tissue away from the contusion core (identified qualitatively from the 
bright field images) either at 2 or 7 days (Figure 3A, B). Small differences are 
apparent when comparing contralateral control tissue between 2 days and 7 days, 
associated with the peaks at 1140, 1462, 1648, and 1660 cm-1 (Figure 3C). Striking 
differences arise between the contralateral controls and the contusion core at 2 days 
(Figure 3D). Some of these resolve with time, in particular the spectral shoulder 
between the peaks at 1562 and 1620 cm-1, which we ascribe to resonance excitation 
of haemoglobin17, but the spectral signatures remain very different compared to 
contralateral also at 7 days (Figure 3E). Comparing the contusion core between 2 
days and 7 days (Figure 3F), interesting spectral differences can be noted in bands 
426, 701, 801, 1128, 1301, 1440, 1462 and 1660 cm-1, associated with lipids. Peaks 
at 426, 675, 754, 1003, 1224, 1547, 1562, 1620 cm-1 are likely due to resonance 
excitation of haemoglobin17; the extensive area of bleeding present at 2 days after 
TBI has largely resolved by 7 days resulting in a decreasing signal of haemoglobin 
(Figure 1A,B). Pericontusional tissue showed similar changes to the contusion core. 
 To isolate the origin of the changing lipid signal observed, we acquired 
average Raman spectra (Figure 4A) of cholesterol (Figure 4B), cholesteryl 
nonanoate (Figure 4C), cholesteryl oleyl carbonate (Figure 4D), as well as a mixed 
lipid solution (intralipid) and protein albumin. The most intense bands from 
cholesterol are at 426, 546, 605, 701, 741, 1128, 1440, 1462 and 1670 cm-1; the bad 
at 1440 cm-1 can be assigned to CH deformation and 1670 cm-1 to C=C stretch 
vibrations9. Additional bands at 1735 cm-1 (ester group) as well as 1029 cm-1 and 
1301 cm-1 (fatty acid chains) are observed in the spectra of cholesterol derivatives. 
Characteristic bands of intralipid (phospholipid stabilized soybean oil) are at 718, 
845, 879, 970, 1064, 1079, 1264, 1301, 1440, 1656 and 1745 cm-1. Symmetric and 
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antisymmetric stretch vibrations of the choline group N+(CH3)3 in phospholipid9 can 
be found at 718 and 879 cm-1. Albumin is the most common α-helical protein with the 
Raman bands at 508, 852, 1003, 1093, 1206, 1339, 1450, 1586, 1604 and 1656 cm-
1.	   Evidence of these Raman bands from cholesterol, cholesterol derivatives, 
phospholipid and protein are observed in our RS data from the brain samples.  
 We used the knowledge of these peak identifications to guide our statistical 
analysis to assess the most significant spatial and temporal changes in the RS data. 
Changes in lipid and protein metabolism are of particular interest biologically after 
TBI in relation to cell damage and inflammatory processes. Unfortunately, many lipid 
and protein Raman signals overlap which makes a clean interpretation difficult. 
Nevertheless, in an attempt to obtain some mechanistic insight, we performed two-
way ANOVA tests using the extracted peak intensity ratios for I(701)/I(718) 
(cholesterol9 / phospholipid7,9; Figure 5A), I(1301)/I(1250) (mixed fatty acid chains7–10 
and amide III protein8,10; Figure 5B), I(1440)/I(1660) (CH deformation7–10 / mixed 
amide I protein7,8,10 and C=C stretching of lipids7–10; Figure 5C), and I(1301)/I(1620) 
(mixed amide III protein8,10 and fatty acid chains7–10 / haemoglobin17; Figure 5D). All 
metrics showed a statistically significant difference between the contralateral and 
pericontusional / contusional regions at 7 days after TBI; all except I(1440)/I(1660) 
also showed changes at 2 days after TBI. I(1301)/I(1250) also showed a significant 
difference between the pericontusional and contusional locations. Interestingly a 
large effect was observed in the ratio I(701)/I(718) demonstrating a significant 
relative increase in cholesterol and decrease in phospholipid contributions. 
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In an attempt to determine a TBI ‘fingerprint’ we subsequently performed 
principal component analysis on the entire data set. The distribution of scores on 
principal components 2 and 3 (Figure 6A) clearly distinguish the contusion and 
pericontusion regions from the distant contusional region and contralateral 
hemisphere, as well as the temporal evolution of the data at 2 and 7 days after TBI, 
based on the illustrated loadings (Figure 6B). From Figure 6A, principal component 2 
is most effective at distinguishing injured and control tissue whereas component 3 
discriminates better at 7 days. From Figure 6B, PC2 is dominated by intense signals 
between 1547 and 1620 cm-1, representing resonance Raman shift from 
haemoglobin and so the acute phase is dominated by the contribution from bleeding 
at / near the contusion site. An important feature of PC3 the peaks at 701 cm-1 
representing an increase in cholesterol signal with respect to the 718 cm-1 
phospholipid peak. 
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Discussion 
RS is a powerful label-free analytical technique that has been widely used to 
study tissue biochemistry. Our results demonstrate that RS can track the evolution of 
TBI over the first 7 days following injury. While the contralateral and ipsilateral distant 
regions are similar at the two time points studied, the spectrum of the contusion core 
is strikingly different already at 2 days after injury and evolves further up to 7 days.  
 One striking spectral feature results from resonant excitation of haemoglobin 
in the pericontusional and contusion core regions, consistent with haemorrhage 
resulting from vascular disruption and bleeding at the lesion18. Haemorrhagic 
conversion and contusion expansion is a potentially devastating pathology after TBI, 
which can lead to oxidative damage and cytotoxicity19 so it is particularly important 
that any non-invasive monitoring technique is sensitive to this process. The 
haemoglobin signals are no longer apparent by 7 days; the macroscopic appearance 
of the tissue is consistent with the phagocytic clearance of erythrocytes and 
endocytosis of haemoglobin and haem by macrophages / microglia20.  
 A second striking spectral feature appears in the pronounced peaks at 701 
cm-1, assigned to cholesterol and 718 cm-1, assigned to phospholipid. Our 
normalised spectra show a relative increase of cholesterol signal and decrease in 
phospholipid in the contusion core compared to the contralateral tissue and over 
time. The relative change at 701/718 cm-1 provides strong evidence of a change in 
lipid chemistry in the pericontusional tissue and contusion core at 2 days that 
remains at 7 days. Cholesterol is known to be critical for cellular repair, in 
neurodegenerative diseases21 and the apolipoproteins involved in cholesterol 
transport are up-regulated at 4 days after TBI22. Furthermore, the ε4 allele of 
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apolipoprotein E has been associated with worse outcomes after TBI23 and 
increased risk of post-TBI dementia24. Interestingly, local cholesterol exposure may 
alter the accessibility of amyloid precursor protein (APP) to β-secretase (Bace1), an 
enzyme responsible for the cleavage of APP to Amyloid-β (Aβ)24,25. The 
accumulation of Aβ is recognised as a pathognomonic mechanism in Alzheimer’s 
and can also be seen within hours of TBI26. These considerations suggest that RS 
could in future provide a probe of these critical mechanisms in TBI pathogenesis.  
Another spectral feature characteristic of the TBI appeared at 1440/1660 cm-1. 
This feature has been used as a marker of the relative concentration of β-sheet 
protein (amide I peak at 1660 cm-1) - a hallmark of amyloid Aβ27. While it is hard to 
disentangle changes in lipid / protein content in regions of the spectrum around 1440 
and 1660 cm-1, RS clearly identifies changes in lipid content with respect to protein, 
consistent with previous findings11. A final feature of note is the increased 
heterogeneity of measurements between the contusion and pericontusional tissue 
reflecting the spatial heterogeneity and temporal evolution of the contusion3,28. 
Further studies combining RS and conventional immunohistochemical analysis will 
allow us to understand the contribution of cell population activation state to the RS 
brain biochemistry.  
There are some limitations to this study. Small differences were observed in 
the 1440/1462 cm-1 and 1648/1660 cm-1 protein / lipid complex between the spectra 
recorded in sham mice and contralateral region of injured mice, as well as between 
the contralateral region at 2 and 7 days. Further work is needed to determine which 
underlying biological changes could impact brain biochemistry far from the contusion 
core. Examples include excitotoxicity, inflammation, blood brain barrier breakdown, 
oedema or intracranial pressure. We are unable, however, from our present data to 
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characterise the cellular population in the volume being probed; correlation with 
histology and immunohistochemistry over space and time is required to fully 
understand the pathological underpinnings of our findings. Nonetheless, since RS 
could be applied in vivo, these findings are promising for tracking the temporal and 
spatial evolution brain tissue biochemistry after injury. 
 
  
15 
	  
Conclusions 
We have shown that RS is a sensitive and reproducible label-free technique for 
monitoring response to TBI. Uniquely, we have used a clinical relevant mouse model 
of parietotemporal contusion and studied both spatial and temporal changes in the 
RS TBI signature. Changes in cholesterol (peak at 701 and 1670 cm-1), phospholipid 
(718 and 1301 cm-1) and protein (1250 and 1660 cm-1) signals as well as a strong 
(resonance) signal from haem (1547 and 1620 cm-1)  are all potentially biologically 
important biomarkers of interest when considering the pathological evolution of TBI. 
RS therefore shows promise both as an experimental tool for the study of TBI as well 
as a possible clinical monitor, allowing therapeutic interventions to be personalised 
and delivered at time points where particular pathobiological mechanisms are 
dominant. Future work is to clearly relate the spatiotemporal spectroscopic changes 
to underlying pathobiology. 
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Figure 1. Raman spectroscopy reveals changes in tissue biochemistry following 
traumatic brain injury (TBI). Bright field microscopy composites of example murine brains 
at 2 days (A) and 7 days (B) after TBI, as well as control (C) (inset photographs show 
sample preparation). Average Raman spectra shown in (D), (E) and (F) were acquired from 
the areas indicated in matching colours in the photos (A), (B) and (C). CL = contralateral; ID 
= ipsilateral distant from contusion core; PC = pericontusional tissue; and CC = contusion 
core. Spectra were acquired at 785 nm, with 1 s exposure and 10 accumulations; the 
average is performed over 30 separate spatial points. 
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Figure 2. Peak identification in average Raman spectra and comparison of the average 
Raman spectra of contralateral with sham control at 2 and 7 days after TBI. (A) 
Average spectrum of the contralateral (CL) and (B) the contusion core (CC). No additional 
peaks were identified at 7 days, so only data from 2 days are shown for clarity. Comparison 
of contralateral to sham brains was made at 2 (C) and 7 (D) days after injury. Spectra were 
acquired at 785 nm, with 1 s exposure and 10 accumulations; the average is performed over 
30 separate spatial points. 
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Figure 3. Comparison of the average Raman spectra at 2 and 7 days after TBI. Each 
panel also shows a difference spectrum for clarity. (A, B) Contralateral (CL) compared with 
ipsilateral distant tissue (ID) are identical at either 2 or 7 days, however, a difference in the 
peaks around 1440 and 1660 cm-1 (C) arises in contralateral tissue over time (between 2 
and 7 days) showing that there are global changes in chemistry remote from the contusion 
even in apparently uninjured tissue. At 2 days after TBI, the spectra from the contusion core 
(CC) and CL are markedly different (D) and these differences evolve rather than normalise 
by day 7 (E, F). Spectra were acquired at 785 nm, with 1 s exposure and 10 accumulations; 
the average is performed over 30 separate points. 
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Figure 4. Raman spectral characterization of lipids. (A) Average Raman spectra of the 
cholesterol (B), cholesteryl nonanoate (C), cholesteryl oleyl carbonate (D) and intralipid (no 
structure shown as mixed lipids). Protein albumin is also shown for reference. Spectra were 
acquired at 785 nm, with 1 s exposure and 10 accumulations at 175 mW; the average is 
performed over 10 separate spatial points. 
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Figure 5. Two-way ANOVA analysis of Raman peak intensity ratios. (A) I(701)/I(718), 
(B) I(1301)/I(1250), (C) I(1440)/I(1660), and (D) I(1301)/I(1620). Replicates used in the 
analysis are: contralateral (CL; n(2 days) = 33, n(7 days) = 33);  pericontusional tissue (PC;  
n(2 days) = 33, n(7 days) = 18) and contusion core (CC; n(2 days) = 8, n(7 days) = 19). Box 
plots indicate means ± SD; *p<0.05 was considered as statistically significant. Spectra were 
acquired at 785 nm, with 1 s exposure and 10 accumulations; the average is performed over 
10 separate spatial points. 
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Figure 6. Principal components analysis of all Raman spectroscopy data. (A) Scatter 
plot of the score values of each single Raman spectrum for the second and third principal 
components from the murine brains 2 days (triangles) and 7 days (circles) after TBI: 
contralateral (CL, black), ipsilateral distant (ID, blue), contusion core (CC, orange) and 
pericontusional tissue (PC, green). (B) Loadings plot of principal components PC1, PC2 and 
PC3 indicating the peaks that contribute to these principal components. 
